These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6376022)

  • 21. Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes.
    Le Roith D
    Diabetes Metab Res Rev; 2007 Nov; 23(8):593-9. PubMed ID: 17922476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Type 2 diabetes: practical guide for starting ambulatory insulin therapy].
    Pernet A; Gheno N
    Rev Med Suisse; 2006 May; 2(68):1453-4, 1456-8,1460-1. PubMed ID: 16783990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin resistance. Receptor and post-receptor abnormalities].
    Liguori M; Urso R; Fatigante G
    Minerva Endocrinol; 1998 Jun; 23(2):37-52. PubMed ID: 9844354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical aspects of the study of insulin receptors].
    De Perro R; Lauro R
    Recenti Prog Med; 1981 Aug; 71(2):170-4. PubMed ID: 7031808
    [No Abstract]   [Full Text] [Related]  

  • 26. [Insulin in the treatment of type 2 diabetes].
    Meyer L; Guerci B; Ziegler O; Drouin P
    Rev Prat; 1999 Jan; 49(1):51-5. PubMed ID: 9926717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing insulin sensitivity.
    Colberg SR
    Diabetes Self Manag; 2007; 24(2):47-50. PubMed ID: 17410671
    [No Abstract]   [Full Text] [Related]  

  • 28. Was insulin review biased, or simply a victim of bad timing?
    Heise T
    J Fam Pract; 2007 May; 56(5):E1-4; author reply E1-4. PubMed ID: 17611994
    [No Abstract]   [Full Text] [Related]  

  • 29. Was insulin review biased, or simply a victim of bad timing?
    Brunton S
    J Fam Pract; 2007 May; 56(5):E1-4; author reply E1-4. PubMed ID: 17475156
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new aspect in diabetes treatment. Results of an orally administered insulin mimetic].
    Winckler T
    Pharm Unserer Zeit; 2001; 30(2):131-4. PubMed ID: 11279983
    [No Abstract]   [Full Text] [Related]  

  • 31. [Insulin or insulin + oral hypoglycemic drugs in the treatment of type 2 diabetes difficult to compensate metabolically?].
    Carta Q; Trovati M; Dani F; Caselle MT; Vitali S; Cavalot F; Rocca G; Cantino G; Mularoni E; Libertucci D
    Minerva Endocrinol; 1984; 9(2):241-5. PubMed ID: 6390138
    [No Abstract]   [Full Text] [Related]  

  • 32. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes.
    Wiernsperger NF
    Diabetes Metab; 1999 Jun; 25(2):110-27. PubMed ID: 10443322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nature of type 2 diabetes: the role for new agents.
    Taylor R
    Int J Clin Pract Suppl; 1999 Jul; 104():14-7; discussion 18-20. PubMed ID: 12669733
    [No Abstract]   [Full Text] [Related]  

  • 34. [Oral hypoglycemics and insulin action. Post-receptor effects].
    Pezzino V; Purrello F; Buscema M; Italia S; Vigneri R
    Minerva Endocrinol; 1986; 11(1):49-53. PubMed ID: 2875387
    [No Abstract]   [Full Text] [Related]  

  • 35. Thioctic acid--effects on insulin sensitivity and glucose-metabolism.
    Jacob S; Rett K; Henriksen EJ; Häring HU
    Biofactors; 1999; 10(2-3):169-74. PubMed ID: 10609878
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of insulin secretion.
    Levine R
    Physiol Pharmacol Physicians; 1966 Dec; 1(12):1-3. PubMed ID: 5981416
    [No Abstract]   [Full Text] [Related]  

  • 37. VIth International Symposium on Insulin Receptors and Insulin Action, Molecular and Clinical Aspects. Copenhagen, Denmark, May 6-10, 1996. Abstracts.
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 2():1-189. PubMed ID: 8882850
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin effect on lung diffusion: NO pathway.
    Boulbou M; Gourgoulianis K; Molyvdas PA
    Am J Respir Crit Care Med; 2003 Aug; 168(3):398; author reply 398-9. PubMed ID: 12888613
    [No Abstract]   [Full Text] [Related]  

  • 39. The identification of TNFR5 as a therapeutic target in diabetes.
    Turner MD
    Expert Opin Ther Targets; 2017 Apr; 21(4):349-351. PubMed ID: 28281898
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical response and the amount of insulin extractable from the pancreas in diabetic patients treated with oral hypoglycaemic drugs: a report on five cases.
    BOGOCH A; DAVIS TW; JOW E; WRENSHALL GA
    Can Med Assoc J; 1959 Sep; 81(5):347-56. PubMed ID: 13802132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.